AGN to break downward?Aegon - Intraday - We look to Sell a break of 4.578 (stop at 4.757)
Although the bulls are in control, the stalling positive momentum indicates a turnaround is possible.
The primary trend remains bearish.
Trading within a Corrective Channel formation.
A break of the recent low at 4.585 should result in a further move lower.
Trading has been mixed and volatile.
Bearish divergence is expected to cap gains.
Our profit targets will be 4.131 and 4.031
Resistance: 4.750 / 4.800 / 4.900
Support: 4.600 / 4.450 / 4.300
Disclaimer – Saxo Bank Group.
Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis , like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis , as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
AGN
Selling AGN into well known turnaround level.Aegon - Intraday - We look to Sell at 4.898 (stop at 5.021)
4.900 continues to hold back the bulls.
The previous swing high is located at 4.878.
Bespoke resistance is located at 4.900.
4.916 has been pivotal.
Preferred trade is to sell into rallies.
Resistance could prove difficult to breakdown.
Our profit targets will be 4.604 and 4.544
Resistance: 4.800 / 4.900 / 5.200
Support: 4.600 / 4.500 / 4.350
Daily chart for context
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses.
There is a very high degree of risk involved in trading. The technical analysis , like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis , as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
A new opportunity to go long with AegonAfter a good start at the beginning on 3 august, there was a buy signal on the bottom indicator RSI3M3 .
Until 12 august the price was rising very rapidly and gave a good return for all investors.
On the day that the earnings were published the price of this stock plunged back to the price of begin august and created a sell signal.
The price is beneath the start of august and will be setting a bottom before it will go up again.
To take advance of the following long setup, you must wait until there will be a buy signal (green arrow) in the RSI3M3
Before you start your long ride with Aegon, check also the ADT - DeMarker I & DT Bressert that all lines are in a uptrend and you have a green candle.
To earn a 20% profit on this stock will be possible.
Happy trading.
ADutchTourist
Is the Nike swoosh a chart pattern you can trade off?
Hey All, take a look at the chart pattern on AGN, seems to be really consistent, swoosh, then crash then consolidate, swoosh then crash then consolidate.
Have i been looking at too many charts? Seeing things? lol, its a possibility, but it looks to me like we are starting a swoosh down right now after coming off highs at AGN. Either that or we are about to spike, then resume the "swoosh" pattern... lol
Let me know your thoughts!
AGN Long, but caution!Another stock getting some attention during COVD. These guys have a good model, basically standing on the shoulders of others and reworking their formulas to make their own Vaccines. There is potential for this company post covid, provided they get a vaccine going. I took a small stake in this company based on Pre Covid activities. IF they do end up getting a vaccine going, imagine the spike it could see. Mere mention of it made it increase large, I don't even need to draw any trendlines here. This one is kind of a gamble right now, but the rewards could be massive! Short term, i'd say there is some upside potential, but we need to beat others to the punch and get a vaccine out soon. CSE:AGN
AGN - downward channel since 2015This big Pharma has been on the decline since 2015. I see it is in the top of the channel currently. Good opportunity to short to the bottom of the channel, especially with the general market declining.
AGN, is getting higher and higherAGN is on a short confirmed uptrend for right now. This stock will get high, to about 168.50 then resistance levels will be hit at that point cover the gains rinse-n-repeat.
AGN short to mid term bounce is comingIt seems to be pretty close or already has finished the (1) and (2). If this label is not correct, at least a 5 wave down is clear. Watch for a bounce soon.
LONG AGN | Recover since 05/05/2017 will push above SMA200. www.tradingview.com
Stock oversold.
As always. Target is floating and not set . If the trade is successful, I will close once it hit's SMA200 again.
Allergan (AGN) LongAllergan stock has been volatile since the merger with Pfizer was abandoned due to Tax Inversion laws back in April 2016. After a April-August Pattern was successful in predicting a downtrend, there has been an emergence of a bullish pattern. Looking purely at technical's I see the stock hitting the 0.236 fib retracement before the earnings call scheduled for 2nd November. I would then look for a rebound up towards the trend line to the 0.382 fib retracement; and if that is broken then I would look for it to test the July highs at fib 0.618. When you take into account the fundamentals, and the companies trend of positive earnings surprises I believe this stock shows potential.
NEXT WEEK'S EARNINGS TO WATCH: LC, VRX, M, JWN, NVDAWith broad market volatility ebbing, the place to sell premium is with earnings plays for now.
Next week, look to put on options plays shortly before the earnings announcement to capitalize on post-announcement volatility contraction. This little fellahs currently look best for plays:
LC: 5/9 (Monday) after market close. Due to the price of the underlying, short straddle it, if anything. Neither a short strangle or iron condor will be productive unless you go with a larger number of contracts.
VRX: 5/11 (Wednesday). I don't show it as before or after market right now.
M: 5/11 (Wednesday) before market open.
JWN: 5/12 (Thursday) after market close.
NVDA: 5/12 (Thursday) after market close.
I also looked at a couple of others, but decided that they were problematic for one reason or another:
TEVA ... is scheduled to announce on Monday, is an ADR. I'm not a huge fan of ADR's, since they're basically free to tentatively schedule an earnings announcement and then move it back a week or two. For a volatility contraction play, which I want to put on immediately before the announcement, this does me no good ... . Moreover, the spreads are wide on the options; if they're wide going in, they're going to be wide trying to get out ... .
SCTY ... will announce on 5/9 after close. I would love to play this little fellow, as it's plenty full of premium given its relatively modest price. That being said, it's another "spread wide" situation ... .
AGN ... announces on 5/10 before market open. You would think an underlying that trades 4.9 million shares on a daily basis would have fairly decent spreads on their options. Nunh-unh ... .
RAX ... 5/9 after market close is the announcement. You guessed it -- illiquid options.
I'll post actual setups as we get closer to earnings ... .
$VRX - Possible downfall, acqusition of $AGN not doneDue to worse than expected ER, and lowered guidance, and top of all failed $AGN acquisition, it is very possible that $VRX is going to $90-$100 price level. Company is not profitable and even if their international profits rise (mostly Russia and Europe), there are problems in creating sustainable growth.